• Accueil
  • Mediakit 🇫🇷 🇬🇧
    • Programme rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧
logo
  • Mediakit 🇫🇷 🇬🇧
    • Programme Rédactionnel
    • Tarifs
    • Formats & infos techniques
    • Diffusion
  • Agenda
  • La Revue
  • L’équipe
  • Podcasts & vidéos
  • Derniers numéros
S'abonner / subscribe linkedin
  • Accueil
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
    • Matériel
    • Matériaux
    • Emballages
  • News 🇬🇧

With Copernicus acquisition, Nemera wants to boost parenteral product portfolio and small series capabilities

News 🇬🇧

publié le vendredi 30 octobre 2020

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus.

Copernicus, based in Szczecin Poland, specializes in the development and manufacturing of injection devices. Their range of reusable and disposable pen injectors are tailored for the treatment of several chronic pathologies. Founded in 2004, Copernicus is regarded as one of the most valued innovative companies in the Polish health sector. They provide a comprehensive range of services in the introduction of modern and intuitive parenteral drug delivery devices.

This acquisition reinforces Nemera’s vision of becoming the most patient-centric drug device combination solutions company. It bolsters our small series production capabilities, R&D expertise and parenteral product offering. Most importantly it expands our overall proprietary product portfolio. Copernicus’ fast and agile clinical manufacturing, adapted for small series, complements Nemera’s historical large-scale manufacturing capabilities.

Texte Alternatif

Furthermore, Copernicus’ marketed reusable pen injectors are of great value from a sustainability standpoint. With this acquisition, the company establish an operations footprint in Eastern Europe. In order to accompany Copernicus’ solid forecasted growth, they will work together to build a new state-of-the-art manufacturing facility in Szczecin, Poland.

“This acquisition is a great strategic and cultural fit for us. Copernicus’ strong focus on patient needs aligns perfectly with our purpose of always putting the patient at the center of everything we do. We’re about to write a new chapter of Nemera’s growth story and I’m really excited about our bright future,” said Marc Hämel, CEO of Nemera.

All rights reserved except agreement written by Emballage Digest or mention of the magazine

Article Précédent
Coval développe un caisson à vide pour la préhension de masques de protection
Article Suivant
CTI launches water-based glow-in-dark ink formulas

Industrie

Matériaux

News 🇬🇧

DIC India Inaugurates its new facility in Gujarat

publié le vendredi 24 mars 2023

Machines

News 🇬🇧

pharmacie

3D screen printing: new partnership between Hovione and Laxxon Medical

publié le jeudi 23 mars 2023

Matériel

News 🇬🇧

Termoplast relies on surface inspection systems from BST

publié le mercredi 22 mars 2023

Matériaux

News 🇬🇧

Securikett launches fully transparent security label with wow effect

publié le lundi 20 mars 2023

Abonnements

Trouvez l'abonnement qui vous convient

voir les offres
logo de Emballage Digest
  • Linéaires
  • Alimentaire
  • Parfumerie & Cosmétique
  • pharmacie
  • Industrie
  • News 🇬🇧
  • Derniers numéros
  • L’équipe
  • Mediakit 🇫🇷 🇬🇧
  • La Revue
  • Agenda
  • Podcasts & vidéos
Mentions légales | Site conçu et réalisé par DEV INFLUENCE

© EMBALLAGE DIGEST - Tous droits réservés